GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » ROC %

Chenguang Biotech Group Co (SZSE:300138) ROC % : 4.80% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Chenguang Biotech Group Co's annualized return on capital (ROC %) for the quarter that ended in Dec. 2024 was 4.80%.

As of today (2025-04-16), Chenguang Biotech Group Co's WACC % is 6.80%. Chenguang Biotech Group Co's ROC % is 3.08% (calculated using TTM income statement data). Chenguang Biotech Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Chenguang Biotech Group Co ROC % Historical Data

The historical data trend for Chenguang Biotech Group Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co ROC % Chart

Chenguang Biotech Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.70 8.22 8.42 7.59 2.80

Chenguang Biotech Group Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.56 3.35 4.07 3.97 4.80

Chenguang Biotech Group Co ROC % Calculation

Chenguang Biotech Group Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2024 is calculated as:

ROC % (A: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2023 ) + Invested Capital (A: Dec. 2024 ))/ count )
=259.712 * ( 1 - 27.11% )/( (6710.081 + 6835.091)/ 2 )
=189.3040768/6772.586
=2.80 %

where

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=8539.58 - 327.164 - ( 1502.335 - max(0, 3952.022 - 6366.849+1502.335))
=6710.081

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9022.521 - 376.855 - ( 1810.575 - max(0, 4596.09 - 6808.992+1810.575))
=6835.091

Chenguang Biotech Group Co's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=283.716 * ( 1 - -0.38% )/( (5038.503 + 6835.091)/ 2 )
=284.7941208/5936.797
=4.80 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7749.738 - 264.513 - ( 2552.132 - max(0, 3118.705 - 5565.427+2552.132))
=5038.503

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9022.521 - 376.855 - ( 1810.575 - max(0, 4596.09 - 6808.992+1810.575))
=6835.091

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chenguang Biotech Group Co  (SZSE:300138) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Chenguang Biotech Group Co's WACC % is 6.80%. Chenguang Biotech Group Co's ROC % is 3.08% (calculated using TTM income statement data). Chenguang Biotech Group Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Chenguang Biotech Group Co ROC % Related Terms

Thank you for viewing the detailed overview of Chenguang Biotech Group Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chenguang Biotech Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Executives
Li Feng Fei Executives
Zhou Jing Directors, Directors, and Executives
Li Yue Zhai Director
Lian Yun He Executives
Chen Yun Xia Executives
Zhao Tao Supervisors
Yuan Xin Ying Supervisors
Liu Zhang Lin Independent director
Lu Qing Guo Directors, executives
Zhou Fang Sheng Independent director
Wang Shu Hong Independent director
Liu Ying Shan Director
Han Wen Jie Executives
Liu Dong Ming Supervisors
Yang Wen Fang Supervisors

Chenguang Biotech Group Co Headlines

No Headlines